BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

8 articles for KW Copeland

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity.EBI
Amgen
Discovery of potent and selective 8-fluorotriazolopyridine c-Met inhibitors.EBI
Amgen
Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.EBI
Amgen
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors.EBI
Amgen
Discovery of triazine-benzimidazoles as selective inhibitors of mTOR.EBI
Amgen
1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of NaEBI
Amgen
Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists.BDB
Abbott Laboratories